Lista de obras -

A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations

artículo científico publicado en 2011

A new recombinant virus system for the study of HIV-1 entry and inhibition

artículo científico publicado en 2005

COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification.

artículo científico publicado en 2014

Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response

artículo científico publicado en 2013

Engineering and screening the N-terminus of chemokines for drug discovery

artículo científico

European recommendations for the clinical use of HIV drug resistance testing: 2011 update

artículo científico publicado el 1 de abril de 2011

Evaluation of saliva as an alternative matrix for monitoring plasma Zidovudine, Lamivudine and nevirapine concentrations in Rwanda

artículo científico publicado en 2011

Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors

artículo científico

Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia

artículo científico publicado en 2014

HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda

artículo científico

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

artículo científico publicado en 2013

HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].

artículo científico publicado en 2013

Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006

artículo científico publicado en 2008

Hypertension burden in Luxembourg: Individual risk factors and geographic variations, 2013 to 2015 European Health Examination Survey.

artículo científico publicado en 2016

Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates

artículo científico publicado en 2011

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

artículo científico publicado en 2014

Isolation of an HIV-1 neutralizing peptide mimicking the CXCR4 and CCR5 surface from the heavy-chain complementary determining region 3 repertoire of a viremic controller

artículo científico publicado en 2016

Limited cross-border infections in patients newly diagnosed with HIV in Europe

artículo científico publicado en 2013

Longitudinal use of a line probe assay for human immunodeficiency virus type 1 protease predicts phenotypic resistance and clinical progression in patients failing highly active antiretroviral therapy

artículo científico publicado en 2002

Longitudinal use of phenotypic resistance testing to HIV-1 protease inhibitors in patients developing HAART failure

artículo científico publicado en 2002

Near Full-Length Characterization and Population Dynamics of the Human Immunodeficiency Virus Type I Circulating Recombinant Form 42 (CRF42_BF) in Luxembourg

artículo científico publicado en 2015

Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection

artículo científico publicado en 2014

Non-immunized natural human heavy chain CDR3 repertoires allow the isolation of high affinity peptides mimicking a human influenza hemagglutinin epitope

artículo científico publicado en 2007

Patterns of transmitted HIV drug resistance in Europe vary by risk group

artículo científico publicado en 2014

Phages and HIV-1: from display to interplay

artículo científico publicado en 2012

Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir

artículo científico publicado en 2010

Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface

artículo científico publicado en 2019

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

artículo científico publicado en 2005

Rescue of HIV-1 long-time archived X4 strains to escape maraviroc

artículo científico

Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor

artículo científico publicado en 2002

Selection of a CXCR4 antagonist from a human heavy chain CDR3-derived phage library

artículo científico publicado en 2011

Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking

artículo científico publicado en 2013

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

article

The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission

artículo científico publicado en 2016

The global spread of HIV-1 subtype B epidemic

artículo científico publicado en 2016

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

artículo científico publicado en 2009

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

artículo científico publicado en 2015

Transmission of drug-resistant HIV-1 is stabilizing in Europe

artículo científico publicado en 2009

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database

artículo científico publicado en 2008

Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

artículo científico publicado en 2012

Uncommon mutations at residue positions critical for enfuvirtide (T-20) resistance in enfuvirtide-naive patients infected with subtype B and non-B HIV-1 strains

artículo científico publicado en 2003

Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system

artículo científico publicado en 2004

Lista de obras de

A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations

A new recombinant virus system for the study of HIV-1 entry and inhibition

COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification.

Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response

Engineering and screening the N-terminus of chemokines for drug discovery

European recommendations for the clinical use of HIV drug resistance testing: 2011 update

Evaluation of saliva as an alternative matrix for monitoring plasma Zidovudine, Lamivudine and nevirapine concentrations in Rwanda

Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors

Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia

HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].

Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006

Hypertension burden in Luxembourg: Individual risk factors and geographic variations, 2013 to 2015 European Health Examination Survey.

Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

Isolation of an HIV-1 neutralizing peptide mimicking the CXCR4 and CCR5 surface from the heavy-chain complementary determining region 3 repertoire of a viremic controller

Limited cross-border infections in patients newly diagnosed with HIV in Europe

Longitudinal use of a line probe assay for human immunodeficiency virus type 1 protease predicts phenotypic resistance and clinical progression in patients failing highly active antiretroviral therapy

Longitudinal use of phenotypic resistance testing to HIV-1 protease inhibitors in patients developing HAART failure

Near Full-Length Characterization and Population Dynamics of the Human Immunodeficiency Virus Type I Circulating Recombinant Form 42 (CRF42_BF) in Luxembourg

Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection

Non-immunized natural human heavy chain CDR3 repertoires allow the isolation of high affinity peptides mimicking a human influenza hemagglutinin epitope

Patterns of transmitted HIV drug resistance in Europe vary by risk group

Phages and HIV-1: from display to interplay

Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir

Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

Rescue of HIV-1 long-time archived X4 strains to escape maraviroc

Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor

Selection of a CXCR4 antagonist from a human heavy chain CDR3-derived phage library

Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission

The global spread of HIV-1 subtype B epidemic

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

Transmission of drug-resistant HIV-1 is stabilizing in Europe

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database

Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

Uncommon mutations at residue positions critical for enfuvirtide (T-20) resistance in enfuvirtide-naive patients infected with subtype B and non-B HIV-1 strains

Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system